The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading ->
This week is World Antimicrobial Awareness Week, marking the fight against the silent and rising global threat of antimicrobial-resistant superbugs. Can patients be part of the solution? This week is the World Antimicrobial Awareness Week (WAAW) when we turn the world’s attention to the growing problem of drug resistant diseases – caused by bacteria, viruses […] Continue reading ->
WHO on Friday issued formal guidelines recommending against the use of remdesivir for COVID-19 patients, based on a lack of evidence that the antiviral drug, developed by Gilead, significantly improves patient outcomes. The recommendation followed publication of trial results on the drug in the The BMJ involving more than 7,000 patients who had been hospitalized […] Continue reading ->
A tier system to assess transmission and public health responses may be able to avoid the economic fallout from long term COVID-19 lockdowns, while combatting transmission of the disease, WHO has said. The European region has recorded over 15.7 million total COVID-19 cases, over 4 million of which occurred in November alone. Europe now accounts […] Continue reading ->
Nearly 100 World Trade Organization member countries and entities could potentially swing behind a proposal by India and South Africa to enact a wide-ranging waiver of complex World Trade Organization requirements on the use of patented products, trade secrets and copyrights on health products during the pandemic, asserted the Médecins Sans Frontières (MSF) Access […] Continue reading ->
Finding the right combination of open innovation – that is the free sharing of expertise, knowledge and data – and intellectual property (IP) that may drive private investments in expensive new technologies, can be a difficult balancing act to attain. But as the COVID-19 pandemic has underlined, it is more and more critical to etch […] Continue reading ->
Use of Ayurvedic medicines, already on the rise worldwide, has soared even higher during the pandemic. But few people may be aware that at least one country, India, actually has an entire ministry devoted to promoting use of these traditional remedies, that have been used for centuries: the Indian Ministry for Ayurveda, Yoga, Unani, Siddha, […] Continue reading ->
The U.S. Food and Drug Administration has issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test for self-testing at home and that provides rapid results. The Lucira COVID-19 All-In-One Test Kit is a molecular-based single use test that is intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19. “While COVID-19 diagnostic […] Continue reading ->
A panel of experts have called for cautious, strategic and realistic approaches in rolling digital tools out to ensure that patients remain a priority. Speaking at the Geneva Health Forum on Tuesday, panellists noted that while the expectations for digital health are high, stakeholders need to be aware that digital health tools alone will not […] Continue reading ->
Women must be exposed to digital technology as both users and innovators – in order to fashion and expand AI designs that meet the needs of hard-to-reach populations, said experts at a Geneva Health Forum. Speaking at the session ‘How Can The World Advance Towards AI Maturity In Health?’ on Monday, Roopa Dhatt, executive director […] Continue reading ->
You must be logged in to post a comment.